Objectives: Quinolone-resistant Escherichia coli (QREC) primarily emerge in commensal bacteria under selective pressure. The aim of this work was to investigate the characteristics of QREC from the faecal microbiota after quinolone exposure, as they remain largely unknown.
Introduction
The microbiota plays a major role as a natural reservoir of bacterial resistance. 1, 2 The huge number and diversity of bacteria in the human microbiota (estimated at 10 14 cells, of which the majority reside in the gut 3 ) form an immense breeding ground for the evolution and transfer of antibiotic resistance genes. 4 Clinical consequences of antibiotic resistance in the gut microbiota include inter-individual transmission of resistant organisms and infections with antibiotic-resistant commensals.
Fluoroquinolones are among the most prescribed antibiotics in the world. The direct consequence is the rapid emergence of fluoroquinolone resistance worldwide, both in hospital settings and in the community. 5 -7 Emergence of fluoroquinolone resistance is responsible for clinical failures and promotes the emergence of multiresistant bacteria. 8 -10 Fluoroquinolones achieve high concentrations in the faeces, which explains their important effect on the gut microbiota. At the species and phylum levels, the composition of the human distal microbiota is significantly altered quantitatively and qualitatively after ciprofloxacin treatment. 11 Another important aspect of the effect of antibiotics on gut microbiota is the risk of emergence of resistance among clinically relevant bacteria, of which Escherichia coli is the major representative.
Previous studies by our group have shown that the emergence of resistance to fluoroquinolones in E. coli colonizing the gut of healthy volunteers treated with ciprofloxacin is a frequent phenomenon detected after exposure, when no more selective pressure by ciprofloxacin was present. 12 -14 Our findings also suggested that the resistant strains were acquired exogenously through inter-individual contacts or food. 13 Additionally, a few subjects who harboured quinolone-resistant strains before treatment still carried the same strains 1 month after treatment. Both the emerging and resilient resistant strains, retrieved a month after ciprofloxacin exposure, were therefore able to persist in the gut microbiota in the absence of ciprofloxacin selective pressure, suggesting they may have selective advantages other than resistance. 13 Yet clinically relevant resistance in E. coli requires multiple genetic changes, including mutations altering topoisomerases that are usually associated with reduced bacterial fitness in vitro and in vivo.
15 -17 However, fitness costs associated with resistance may be compensated by genetic co-selection, compensatory evolution and even additional resistance mutations. 16, 18 The aim of this work was to determine whether quinolone-resistant E. coli (QREC) persisting after antibiotic pressure in the microbiota of volunteers after ciprofloxacin treatment have selective advantages or higher fitness, allowing them to survive in the microbiota, compared with quinolone-susceptible E. coli (QSEC) from the same subjects. We analysed QREC and compared them with QSEC collected before and after ciprofloxacin exposure: (i) genetically, by characterizing intra-host diversity, phylogenetic group and virulence factor content; (ii) in vitro, by measuring growth rates in different media and general stress regulator RpoS activity, including iodine staining and specific responses to oxidative and acid stresses; and (iii) in vivo, by determining colonization capacities in a mouse colonization model and in the subjects themselves.
Materials and methods

Studied isolates
For this work we used the samples from a previous study, the CIPHARES trial. Forty-eight healthy volunteers had been selected and had provided faecal samples. 12 They had received different therapeutic regimens of oral ciprofloxacin for 14 days. Subjects were 18-45 years old, had no previous medical condition, had not received any antimicrobials or steroids for at least 3 months before the trial and were on their usual diet during the study. Faecal samples were collected on day 0 and day 42. Ciprofloxacin was taken under supervision. Subject selection, ciprofloxacin regimens, drug concentrations in faeces and plasma, sample collection and detection of quinolone-resistant isolates were described elsewhere, 12 as were antibiotic susceptibility patterns and the mechanisms of quinolone resistance. 12, 13 Among these 48 subjects, 14 retained QREC at day 42: 10 experienced emergence of resistance to quinolones only at day 42, from an initial susceptible flora at day 0 (subjects V34-42 and V46); and 4 subjects carried QREC on day 0 and day 42 (V44, V45, V47 and V48). Thirty-three subjects did not experience colonization by QREC at any time, of whom 29 had samples available for this work. One subject, who carried both QSEC and QREC on day 0, carried only QSEC on day 42, and was not analysed in this work (V43). 13 Altogether, 43 subjects could be analysed for this work. For each of these subjects, at each timepoint, five random colonies were picked on the plates containing no antibiotic and on the antibioticcontaining plates. If isolates were present on both nalidixic acid and ciprofloxacin plates, only isolates growing on ciprofloxacin plates were collected.
Genetic characterization of strains
Diversity of E. coli among five random colonies
For each faecal sample, the five randomly picked colonies were compared with each other by random amplified polymorphic DNA (RAPD) assay using the primer 1254 (5 ′ -CCGCAGCCAA-3 ′ ), after DNA extraction, as described previously. 19 We compared five colonies to provide a good reflection of the polymorphism of E. coli in faecal samples. 20 Accordingly, for each subject at each collection date, the number of distinct RAPD genotypes of E. coli was determined; it ranged from one to five.
Phylogenetic group E. coli phylogenetic groups were determined for strains with distinct RAPD patterns using a triplex PCR assay. 21 
Virulence factor content
The presence of 18 virulence factors representative of the main classes of identified E. coli extraintestinal virulence determinants, including adhesins (papC, papG, sfa-foc, iha, hra and ibeA), toxins (hlyC, cnf1 and sat), iron capture systems (fyuA, irp2, iroN, iucC and ireA), protectins (neuC, chromosomal ompT and traT), as well as usp, a gene encoding a uropathogenicspecific protein, was tested by PCR. 22 
In vitro growth experiments
Growth experiments were performed on each single distinct RAPD-pattern strain.
Maximum growth rates (MGRs)
Strains were grown at 378C in two different media in 2.2 mL wells with a diameter of 1 cm: Luria-Bertani (LB) and minimal medium with gluconate at 20 mM. Minimal medium with gluconate was used because gluconate appears to be the major source of carbon used by E. coli to colonize the gut, having an impact on both the initiation and maintenance stages. 23 Bacterial cells grew overnight at 378C with constant agitation at 250 rpm, and were transferred into a fresh medium at a dilution of 1 :10000; the plates were agitated at 100 rpm for 20 s. Growth was then recorded by an Infinite 200 Tecan w spectrophotometer, which measured the optical density at 600 nm (OD 600 ) in each well every 5 min at 378C for 24 h. OD 600 values were collected and log-transformed. The MGR was calculated and expressed in h 21 as previously described. 24 Experiments were repeated three times. All MGRs were compared by strain and media using a Welch test.
RpoS activity and resistance to various stresses
The activity of the general stress regulator RpoS in the bacterial cells was investigated at several levels. 25 First, it was assessed indirectly by the estimation of the level of glycogen in the cells. After overnight subcultures in flasks, strains were spotted on LB agar plates incubated overnight at 378C and then left at 48C for 20 h before being flooded with lugol solution containing iodine. Iodine staining is dependent on glycogen, whose synthesis is positively regulated by RpoS through the glycogen synthesis protein gene, glgS.
26 Dark brown colonies correspond to a high level of RpoS, whereas colonies of DrpoS mutant strains remain pale. 27 Each isolate was placed in triplicate on the same agar plate. A negative control corresponding to E. coli K-12 MG1655 DrpoS strain and a positive control with high RpoS activity were used. 27 The percentage of darkness was measured for each isolate using computer-based attribution of the colour intensity percentage (relative intensity) for each spot, on the basis of correction with respect to two controls (0 and 100%), as described previously. 28 Second, the potential of the strains to directly resist physiologically relevant stresses, i.e. H 2 O 2 and acid, was assessed in two separate experiments. Strains were cultured at 378C in LB medium in the presence of H 2 O 2 at a concentration of 5 mM and at pH 3 for 60 min. Positive and negative controls identical to those used in the iodine staining assay were included. Colonies were counted on agar plates at times 0 and 60 min. Results are expressed as percentages, de Lastours et al.
corresponding to the number of cfu at 60 min divided by that at time 0 (before the stress). 28 Lastly, rpoS gene sequencing was performed as described previously in all the resistant strains. 28 
Mouse intestinal colonization assay
We selected three pairs of strains collected in three volunteers to test in the model. For each pair, we compared a pre-exposure QSEC from day 0 with the post-exposure QREC that emerged at day 42. We chose three QREC with different levels of resistance to quinolones and numbers of mutations ( Table 1 ). All six strains were streptomycin susceptible. Six-week-old female mice (Charles River CD-1) pretreated with streptomycin were used to monitor the ability of E. coli strains to colonize the intestine of a mammalian host. Mice were isolated and had free access to sterile food and drinking water supplemented with streptomycin sulphate (5 g/L) for 5 days. The mice then did not receive streptomycin for 5 days before bacterial inoculation. This colonization assay allows the subsequent colonization of the mouse intestine by streptomycin-susceptible strains. 24 Furthermore, this assay has been found to be a very powerful way of differentiating the colonization capacities of various strains in the presence of competitors. 24 Antibiotic treatment efficiency against the coliform intestinal population before inoculation was controlled by plating a pure suspension of faeces on Drigalski selective agar medium. On the day of inoculation, 10 6 E. coli bacteria were administered in 200 mL of PBS by the oral route to mice with the QSEC and QREC strains mixed at a ratio of 1: 1. At days 1, 2, 5, 7 and 8 following bacterial administration, the sizes of bacterial populations in the intestine of mice were evaluated by plating dilutions of weighed fresh faeces on LB agar supplemented or not with nalidixic acid or ciprofloxacin, with concentrations depending on the MIC of the tested resistant strain. Ten strains excreted in the faeces were compared with the infection strains (both QREC and QSEC) by RAPD-PCR, to confirm they were identical. Three mice were used for each pair of strains tested. A colonization index was calculated as previously described. 24 All experiments were performed in compliance with the recommendations of the French Ministry of Agriculture and the French Veterinary Services (accreditation number A75-18-05).
E. coli counts from volunteers' faecal samples
To quantify and compare the relative amounts of QSEC and QREC collected on day 42 in the same volunteers, the number of cfu on Drigalski medium with and without quinolones was quantified after repeated dilutions. The abundance of susceptible strains was determined for 100 cfu growing on media without antibiotic by reculturing each colony on media with and without quinolones. Accordingly, the limit of detection of the relative abundance of susceptible-to-resistant strains was estimated to be 10
22
.
Statistical analysis
Fisher's exact test, Mann-Whitney and Kruskal-Wallis tests were used to compare qualitative and quantitative data, as appropriate. Statistical analyses were performed using SAS v9.3 software (SAS Institute Inc., Cary, NC, USA). P,0.05 was considered significant.
Ethics
The original CIPHARES trial study design was approved by the local ethics committee of Paris Bichat-Cergy Pontoise. 12 All participants gave written informed consent before entering the study (Clinical Trials registration: NCT00190151).
Results
Intra-host diversity
Two hundred and fifteen pre-exposure QSEC isolates from 43 subjects on day 0 and 145 post-exposure QSEC from 29 subjects on day 42 were available. On day 42, the remaining 14 subjects also had QREC detected, but in 3 subjects no QSEC was evidenced. 13 Therefore, an additional 55 QSEC isolates (from 11 subjects) and 70 QREC isolates (from 14 subjects) were collected on day 42. Altogether, 485 isolates were available for further analyses: 215 QSEC from day 0, 200 (145 + 55) QSEC from day 42 and 70 QREC from day 42. Among the five randomly picked colonies, a median of 2 (range 1 -4) distinct RAPD genotypes were found among QSEC and only one single resistant RAPD genotype was found among five isolates for QREC on day 42 (P,0.01). Altogether, 60, 56 and 14 distinct RAPD genotypes were determined among the 215 day 0 QSEC, the 200 day 42 QSEC and the 70 day 42 QREC, respectively. Further experiments were performed only on strains with distinct RAPD genotypes: 116 QSEC (60 day 0 QSEC and 56 day 42 QSEC) and 14 QREC. Of note, the QREC strains from the different subjects had been compared with each other in the previous work and all had distinct RAPD patterns. 13 
Phylogenetic group membership
The distribution of phylogroups differed between QSEC and QREC, though not significantly. Indeed, among the 60 different QSEC collected on day 0, 27 (45%), 9 (15%), 14 (23%) and 10 (17%) belonged to phylogroups A, B1, B2 and D, respectively. A similar distribution was found among the 56 QSEC collected on day 42: 28 (50%), 11 (20%), 7 (12%) and 10 (18%) for phylogroups A, B1, B2 The volunteers' numbers correspond to those in our previous work. 13 AMX, amoxicillin; SXT, co-trimoxazole.
High-fitness quinolone-resistant E. coli 763 JAC and D, respectively. On the other hand, QREC on day 42 belonged predominantly to groups A (7, 50%) and D (6, 43%), with only one strain belonging to the B2 group and no B1 strain.
Virulence factor content QREC (n¼ 14) and QSEC (n¼ 116) carried a median of 4 (range 2 -11) and 2 (range 0-11) virulence factors, respectively, among the 18 tested (P ¼ 0.03). Additionally, significantly more QREC carried virulence factors belonging to the iron capture systems than QSEC (90% of strains versus 55%; P ¼0.02) (Figure 1 ). QREC also carried more iron capture coding genes than QSEC (median of 2 versus 1 among the 5 iron capture genes for QREC and QSEC, respectively, P ¼ 0.02). This result is all the more remarkable in that strains of phylogroup A, to which the majority of QREC belong, are devoid of virulence factors when compared with B2 strains. 29 
MGRs, RpoS activity and response to oxidative and acid stresses
Among the 14 QREC, MGRs in minimal medium with gluconate were higher in strains with only one mutation in the quinolone resistance-determining region (QRDR) than in those with two or more mutations (P ¼0.01). No difference was found between these two groups of strains when grown in LB medium (P ¼ 0.7) (Figure 2a ). MGRs in minimum medium with gluconate were also higher in the 3 QREC with no co-resistance than in the 11 carrying co-resistances, although not significantly higher (P ¼ 0.08). for QSEC, P¼0.01) (Figure 2b ). No differences were evidenced in growth rates according to the number of virulence factors or the presence or not of iron capture systems. Iodine staining, H 2 O 2 and acid stress resistance were also higher for QREC than for QSEC (P ¼ 0.01, P¼ 0.002 and P ¼ 0.05, respectively) (Figure 3) , indicating a higher RpoS activity in QREC. This was confirmed by an absence of rpoS mutations in these QREC strains.
Mouse colonization assay
Before bacterial inoculation, none of the nine mice had any enterobacteria in its faeces. Figure 1 . Proportion (%) of strains carrying at least one virulence factor belonging to the four groups of virulence factors, comparing susceptible strains (S; n¼116) and resistant (R; n¼14) strains (*P¼0.015). Figure 2 . Box and whisker plots representing the distribution of MGR in LB and minimal medium with gluconate of E. coli strains. The box and whisker plots display the median values and 25th and 75th percentiles of the distribution; whiskers extend to the most extreme data point that is no more than 1.5 times the IQR from the box. (a) MGR according to the number of mutations in the QRDR [one mutation (n ¼7) or more than one mutation (n ¼7)]. There was no difference in terms of growth in LB (P¼0.7), whereas QREC with only one mutation had a higher MGR in minimal medium with gluconate than those with more than one mutation (*P¼0.01). (b) MGR according to susceptibility to quinolones, comparing susceptible strains (QSEC, n¼56) and resistant strains (QREC, n¼14). There was no difference in terms of growth in LB (P¼0.3), whereas QREC had a higher MGR in minimal medium with gluconate than QSEC (*P¼0.01).
(a)
de Lastours et al.
were collected from day 1 to day 8 in the faeces, showing satisfactory colonization rates of the model. All QREC and QSEC collected from the faeces had RAPD genotypes similar to those of the strains initially inoculated in the mice. Colonization indexes for each of the three mice tested with a pair of QSEC and QREC are shown in Figure 4 . A colonization index above zero meant that QREC outcompeted QSEC, and conversely. In the competition involving the resistant strain with only one mutation in QRDR (V35), QREC outcompeted the susceptible one on three of five sampling days by at least 1.5 log cfu. In the competitions involving the resistant strains carrying two and three mutations in the QRDR (V39 and V41), neither QREC nor QSEC outcompeted the others, as mean colonization indexes were within the+1 log interval, considered as the limit of discrimination.
Faecal populations in volunteers
Results of the relative abundance of QREC versus QSEC colonizing the faeces from the 14 subjects having experienced persistence of QREC on day 42 are shown in Figure 5 . Total counts of E. coli varied, depending on the subject, between 10 4 and 10 7 cfu/g of faeces. Overall, no difference was found between the colonization capacities of the susceptible and resistant strains (P ¼ 0.7). However, in three subjects (subjects V35, V42 and V48) only QREC were detected on the plates (10 4 , 10 5 and 10 5 cfu/g, respectively, for the three subjects), while QSEC were not detectable (as shown by arrows in Figure 5 ), and considered therefore to reach a maximum of 10 2 , 10 3 and 10 3 cfu/g of faeces, respectively. In the 11 remaining volunteers, resistant strains outcompeted the susceptible strains in 6, susceptible strains outcompeted resistant strains in 3, and counts were comparable in 2.
Discussion
Using a unique collection of stool samples collected from healthy volunteers who were treated with ciprofloxacin for 14 days, we studied the diversity, genetic backgrounds, in vitro growth rates, stress resistance and in vivo colonization capacities of QSEC and QREC collected from the same subjects before and after exposure to ciprofloxacin. We found that, when compared with QSEC, QREC persisting at day 42: (i) were monoclonal; (ii) had different phylogenetic backgrounds and carried more iron capture systems; (iii) had higher in vitro fitness and stress resistance due to high RpoS activity; and (iv) had high colonization capacities in a mouse colonization model and in the subjects themselves.
From a genetic point of view, there was a complete shift in phylogroups when resistant and susceptible strains were compared. This is consistent with our previous findings that these resistant strains are genetically distinct from the susceptible E. coli present in the initial flora, before antibiotic consumption. 13 A link between genetic background of E. coli and the pattern of antibiotic resistance has been reported. 30 -32 Strains belonging to phylogroup A 33 and some D group strains 34 are more often resistant to third-generation cephalosporins and quinolones. 35 Conversely, B2 strains are less resistant than the remaining strains, regardless of the molecular mechanism involved in resistance, 36 and had a lower prevalence of integrons in commensal E. coli strains. 37 This could explain the relative decrease in B2 strains in the QREC from these volunteers.
Interestingly, QREC harboured more virulence determinants than QSEC, and this despite their phylogroup. 29 More specifically, they exhibited numerous iron capture systems, which probably partly explains their efficiency in colonizing the gut. Indeed, capturing iron is an essential metabolic advantage in the colon, where multiple microorganisms are fighting to survive. 38 QREC were and acid stress were significantly higher for QREC than for QSEC strains (*P¼0.01, P¼0.002 and P¼0.05, respectively). The box and whisker plots display the median values and 25th and 75th percentiles of the distribution; the whiskers extend to the most extreme data point that is no more than 1.5 times the IQR from the box.
High-fitness quinolone-resistant E. coli 765 JAC also found to have higher growth rates than QSEC in the minimal medium with gluconate, a sugar that is the major source of carbon in the gut. 23 The scarcity of resources in minimal medium with gluconate, including iron, probably explains why the difference between QREC and QSEC was more pronounced in this medium than in the rich LB. As expected, growth rates were particularly high for strains harbouring only one QRDR mutation and no co-resistance to other antibiotics, underlining the specific impact on growth of the accumulation of resistance mutations. QREC from this collection also have a high capacity for stress resistance, largely due to high RpoS activity, a central regulator of stress resistance. 25, 39 We show that QREC survive better than QSEC in the presence of two more specific stresses of major importance for survival in the gut, i.e. oxidative and acid stresses. The QREC studied here have probably been acquired exogenously through food or inter-individual transmission. 13 They have therefore transited in the natural environment outside the host and then needed to survive the acid environment of the stomach and further survive among many competitors in the gut microbiota. This high stress resistance of QREC may be a necessary prerequisite for their survival.
More information is given by the results of the mouse competitive colonization model. They attest that QREC had a high capability to rapidly colonize the intestine, for at least 1 week, despite the presence of competitors and the absence of selective pressure. Finally, we found that QREC persisting after ciprofloxacin in healthy subjects had high colonization capacities in the human gut, as counts of QREC and QSEC were not different among the 14 subjects and even outcompeted QSEC in three subjects. This was the most relevant proof that these strains are perfectly adapted to a commensal lifestyle and that they manage to impose themselves as dominant strains. The fact that no intra-host diversity was found among resistant E. coli also confirms our hypothesis: only one particularly well adapted clone managed to survive after ciprofloxacin exposure. Clonality amongst E. coli is also observed in the prolonged carriage of fluoroquinolone-resistant E. coli. 40 The persistence of a single dominant resistant clone implies that only a limited number of clones in circulation are able to colonize and persist amongst individuals.
Our results are important because they explain why these resistant strains are able to persist in the gut despite the cost of carrying QRDR mutations. 15 The fitness cost of drug resistance can be reduced by the selection of low-cost mutations 18 or by the accumulation of secondary fitness-compensating mutations through compensatory evolution either within the gene 41 or within the biological pathway. 15, 16, 18 Indeed, resistant mutations may be beneficial on certain resistant genetic backgrounds as positive epistasis among alleles that confer resistance to antibiotics may occur. 42 Additionally, genetic co-selection may play a role in the reduction in fitness costs due to resistance. 16 This last hypothesis is most likely to occur in our QREC strains as, despite the fact that they are genetically very heterogeneous, we found in these strains numerous specific traits allowing their adaptation to the gut (iron capture systems, high growth in gluconate and resistance to oxidative and acid stresses). Identifying the precise mutations that reduce fitness cost will be a difficult task as E. coli is so diverse at the genome level 43 that, in the absence of a parental susceptible comparator, 13 many mutations may be detected by full genome sequencing but difficult to interpret. Finally, the role of the rest of the microbiota has not been studied here. Nevertheless, anaerobes in the gut microbiota play an important protective role against colonization by resistant organisms, a phenomenon known as colonization resistance. 44 Studying the composition of this microbiota by high-throughput sequencing methods 45 and comparing subjects with and without emergence of resistance would be of great interest.
In conclusion, QREC colonizing faecal microbiota of subjects after ciprofloxacin treatment, even in the absence of selective pressure, have high growth rates and high capacity to resist physiological stresses and are not hampered in their colonizing capacities in vivo. One resistant clone dominates. The absence of fitness costs due to quinolone resistance appears to be the result of genetic co-selection of numerous traits acquired during multiple different evolutionary paths in these genetically different strains, which Figure 4 . Results of the mouse colonization assay. Colonization indexes for each of the three mice infected with one of the three pairs of resistant and susceptible strains tested. The colonization index is a ratio of ratios in which the ratio between resistant and susceptible strains at post-inoculation timepoints is divided by this same ratio at the initial inoculation time [log cfu (R/S) t*/(R/S) t0]. Broken lines correspond to the +1 log interval, considered as the limit of discrimination.
were of exogenous origin. 13 QREC colonizing faecal microbiota may therefore not easily be eliminated from the faecal microbiota of subjects as they seem perfectly adapted to their environment. This is important because commensal E. coli excreted in the faeces are at risk of dissemination in the environment and between hosts, and may be responsible for extra-intestinal infections. Clinicians should be aware and take account of this potentially dangerous side effect when prescribing ciprofloxacin. V34 V35 V36 V37 V38 V39 V40 V41 V42 V44 V45 V46 V47 V48 S R Subjects E. coli counts (log cfu/g) Figure 5 . Faecal population counts of susceptible (S) and resistant (R) E. coli colonizing subjects on day 42. Arrows indicate the level below which the susceptible strains were not detectable among the dominant resistant strains that outnumbered them (P¼0.69 for all).
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